Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

Erie Homeowners Urged to Schedule Furnace Checks Before Winter

Licensed Remodeler Expands Service to North County Coastal Cities

One Contractor Handles Full Home Remodels Across Houston

Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy...

YogShri Healing: No. 1 Sound Healing Training & Research Institute in Rishikesh, India

Francoobla Music Announces the MAJESTATIS 7+7 Global Protocol: A Proposed Universal Mathematical Standard Against Musical Plagiarism and for...

JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of...

Roofing Contractors in San Antonio Serving Homes & Businesses

Studio 9 Salon Expands On-Location Bridal Services Across Metro Detroit

Beyond Success: Miami Founders Stillness

How Often Should Emergency Lighting Be Tested?

Livonia HVAC Company Urges Five Safety Checks Before the First Cold Snap

A Complete Guide to ANSUL Kitchen Fire Suppression Systems

Brown & Crouppen Warns of 43% Higher Halloween Pedestrian Risk

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and...